CoChat

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

The release and trans-synaptic transmission of Tau via exosomes

Open access

Abstract

BACKGROUND: Tau pathology in AD spreads in a hierarchical pattern, whereby it first appears in the entorhinal cortex, then spreads to the hippocampus and later to the surrounding areas. Based on this sequential appearance, AD can be classified into six stages ("Braak stages"). The mechanisms and agents underlying the progression of Tau pathology are a matter of debate. Emerging evidence indicates that the propagation of Tau pathology may be due to the transmission of Tau protein, but the underlying pathways and Tau species are not well understood. In this study we investigated the question of Tau spreading via small extracellular vesicles called exosomes. METHODS: Exosomes from different sources were analyzed by biochemical methods and electron microscopy (EM) and cryo-EM. Microfluidic devices that allow the culture of cell populations in different compartments were used to investigate the spreading of Tau. RESULTS: We show that Tau protein is released by cultured primary neurons or by N2a cells overexpressing different Tau constructs via exosomes. Neuron-derived exosomal Tau is hypo-phosphorylated, compared with cytosolic Tau. Depolarization of neurons promotes release of Tau-containing exosomes, highlighting the importance of neuronal activity. Using microfluidic devices we show that exosomes mediate trans-neuronal transfer of Tau depending on synaptic connectivity. Tau spreading is achieved by direct transmission of exosomes between neurons. In organotypic hippocampal slices, Tau-containing exosomes in conditioned medium are taken up by neurons and microglia, not astrocytes. In N2a cells, Tau assemblies are released via exosomes. They can induce inclusions of other Tau molecules in N2a cells expressing mutant human Tau. We also studied exosomes from cerebrospinal fluid in AD and control subjects containing monomeric and oligomeric Tau. Split-luciferase complementation reveals that exosomes from CSF can promote Tau aggregation in cultured cells. CONCLUSION: Our study demonstrates that exosomes contribute to trans-synaptic Tau transmission, and thus offer new approches to control the spreading of pathology in AD and other tauopathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-016-0143-y

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Release of Tau via exosomes by cultured rat cortical neurons. Conditioned medium of cortical neurons (DIV14-21) was collected for isolation of exosomes. N denotes neuronal lysates, E exosomal lysates. a Western blot analysis of the distribution of neuronal Tau (left panel, lanes 1, 2) and exosomal markers (Flotillin and Alix, right panel, lanes 3, 4) in neuronal lysates and exosomes. Note: (1) Tau typically appears as two bands, a weaker upper band at Mr ~56kD and a stronger lower band at Mr ~54kD (lane 1). (2) The Tau bands in exosomes have a lower Mr (~50kD and 48 kD) than endogenous rat Tau bands. (3) Less Tau was detected in exosomes than in cell lysates, which is in contrast to Flotillin and Alix, indicating Tau is not a major component of exosomes. b Quantification of Tau in exosomes and in conditioned medium of neuron culture using ELISA. The conditioned medium from neuron culture (DIV17) was depleted of cells and cell debris via sequential centrifugation at 300 × g, 2000 × g for 10 min and 10,000 × g for 30 min. Tau in conditioned medium represents the total extracellular Tau and was used for calculation of the percentage of exosomal and Non-exosomal Tau. c Exosomal Tau is intact and hypophosphorylated: To compare the phosphorylation status of Tau in neuronal lysates and exosomes, neuronal lysates (lane 1) were dephosphorylated with alkaline phosphatase for 30 min at 37 °C (lane 2). This lowers the Mr to the same level as exosomal Tau (lane 3), indicating that the change is due to phosphorylation and not due to truncation. Exosomal Tau is recognized by antibody SA4470 against aa.1-17 of Tau and antibody Tau C-ter against aa.400-441 of Tau (2nd and 3rd panels), indicating that both neuronal and exosomal Tau are intact. d Nanoparticle tracking analysis (NTA) of isolated exosomes showing particle number vs. size (arbitrary units, peak = 100%). The distribution peaks at a diameter of ~75 nm, which is typical for exosomes. e Isolated exosomes separated by sucrose gradient centrifugation. Neuronal lysates (N) and exosomal lysates (E) were loaded for comparison. Note: (1) Tau is enriched in fractions 7 and 8 coincident with the exosomal markers Flotillin and Alix; (2) the Mr values of Tau bands in exosomes are lower than those of endogenous rat Tau bands due to lower phosphorylation, which is consistent with the results shown in A. f Negative stain-electron microscopy of isolated exosomes. Many exosomes appear as cup-shaped vesicles with diameters of 40–100 nm. Scale bar = 70 nm. g Cryo-electron tomography of isolated exosomes. Because of the better preservation, exosomes reveal a more native spheroidal shape. The upper panel (overview) shows that most exosomes (arrows) exhibit a size of 50–100 nm. For one selected exosome we show here (lower panel) an isosurface representation of the membrane to visualize the outer shape of the vesicle
Fig. 1 Release of Tau via exosomes by cultured rat cortical neurons. Conditioned medium of cortical neurons (DIV14-21) was collected for isolation of exosomes. N denotes neuronal lysates, E exosomal lysates. a Western blot analysis of the distribution of neuronal Tau (left panel, lanes 1, 2) and exosomal markers (Flotillin and Alix, right panel, lanes 3, 4) in neuronal lysates and exosomes. Note: (1) Tau typically appears as two bands, a weaker upper band at Mr ~56kD and a stronger lower band at Mr ~54kD (lane 1). (2) The Tau bands in exosomes have a lower Mr (~50kD and 48 kD) than endogenous rat Tau bands. (3) Less Tau was detected in exosomes than in cell lysates, which is in contrast to Flotillin and Alix, indicating Tau is not a major component of exosomes. b Quantification of Tau in exosomes and in conditioned medium of neuron culture using ELISA. The conditioned medium from neuron culture (DIV17) was depleted of cells and cell debris via sequential centrifugation at 300 × g, 2000 × g for 10 min and 10,000 × g for 30 min. Tau in conditioned medium represents the total extracellular Tau and was used for calculation of the percentage of exosomal and Non-exosomal Tau. c Exosomal Tau is intact and hypophosphorylated: To compare the phosphorylation status of Tau in neuronal lysates and exosomes, neuronal lysates (lane 1) were dephosphorylated with alkaline phosphatase for 30 min at 37 °C (lane 2). This lowers the Mr to the same level as exosomal Tau (lane 3), indicating that the change is due to phosphorylation and not due to truncation. Exosomal Tau is recognized by antibody SA4470 against aa.1-17 of Tau and antibody Tau C-ter against aa.400-441 of Tau (2nd and 3rd panels), indicating that both neuronal and exosomal Tau are intact. d Nanoparticle tracking analysis (NTA) of isolated exosomes showing particle number vs. size (arbitrary units, peak = 100%). The distribution peaks at a diameter of ~75 nm, which is typical for exosomes. e Isolated exosomes separated by sucrose gradient centrifugation. Neuronal lysates (N) and exosomal lysates (E) were loaded for comparison. Note: (1) Tau is enriched in fractions 7 and 8 coincident with the exosomal markers Flotillin and Alix; (2) the Mr values of Tau bands in exosomes are lower than those of endogenous rat Tau bands due to lower phosphorylation, which is consistent with the results shown in A. f Negative stain-electron microscopy of isolated exosomes. Many exosomes appear as cup-shaped vesicles with diameters of 40–100 nm. Scale bar = 70 nm. g Cryo-electron tomography of isolated exosomes. Because of the better preservation, exosomes reveal a more native spheroidal shape. The upper panel (overview) shows that most exosomes (arrows) exhibit a size of 50–100 nm. For one selected exosome we show here (lower panel) an isosurface representation of the membrane to visualize the outer shape of the vesicleCC BY · PubMed Central
Fig. 2 Depolarization of neurons stimulates release of exosomes containing Tau. Cortical neurons were incubated in control medium or depolarizing medium containing 25 mM KCl for 3 h. a Cytotoxicity analyzed with LDH release assay. KCl treatment does not cause cell death. Error bars: SD; n = 3. Student t-test: n.s., not significant. b KCl treatment enhances exosomal Tau release. Neurons or exosomes isolated from conditioned medium of control neurons (lanes 1, 3) or depolarized neurons (lanes 2, 4) were lysed for western blot analysis. KCl treatment does not change Tau and Alix levels in neuronal cell lysates (compare lanes 1, 2), but increases both Tau and Alix in exosomes (compare lanes 3, 4). c, d Quantification of blots shown in B for Tau (upper panel) and the exosome marker Alix (bottom panel) in cell lysates (c) or exosomes (d). Shown are the ratios of proteins in cell lysates or exosomes (KCl-induced vs. control). Note that upon neuronal activation by KCl, Tau or Alix in exosomes increase by ~50% (d), whereas Tau or Alix in cell lysates does not change (c). Error bars: SD; n = 4. Student t-test: *p < 0.05; n.s., not significant
Fig. 2 Depolarization of neurons stimulates release of exosomes containing Tau. Cortical neurons were incubated in control medium or depolarizing medium containing 25 mM KCl for 3 h. a Cytotoxicity analyzed with LDH release assay. KCl treatment does not cause cell death. Error bars: SD; n = 3. Student t-test: n.s., not significant. b KCl treatment enhances exosomal Tau release. Neurons or exosomes isolated from conditioned medium of control neurons (lanes 1, 3) or depolarized neurons (lanes 2, 4) were lysed for western blot analysis. KCl treatment does not change Tau and Alix levels in neuronal cell lysates (compare lanes 1, 2), but increases both Tau and Alix in exosomes (compare lanes 3, 4). c, d Quantification of blots shown in B for Tau (upper panel) and the exosome marker Alix (bottom panel) in cell lysates (c) or exosomes (d). Shown are the ratios of proteins in cell lysates or exosomes (KCl-induced vs. control). Note that upon neuronal activation by KCl, Tau or Alix in exosomes increase by ~50% (d), whereas Tau or Alix in cell lysates does not change (c). Error bars: SD; n = 4. Student t-test: *p < 0.05; n.s., not significantCC BY · PubMed Central
Fig. 3 Tau is localized inside exosomes. a Neuron-derived exosomes were incubated with increasing concentrations of NaCl to detach proteins peripherally attached to the membrane. Tau is detected with the pan-Tau antibody K9JA. HSC70 and Alix were examined as exosomal markers. Lines on the right indicate Tau protein, Alix and HSC70. M.W. markers are shown on the left. Note that exosomal Tau levels are not changed by NaCl treatment (lanes 1–5), similar to exosomal markers HSC70 and Alix, indicating that Tau is not peripherally attached to the exosomal membrane surface. b Proteinase K protection assay. Neuron-derived exosomes treated with or without 50 ng proteinase K (Prot K) in the presence or absence of 1% saponin (Sapo) for 5 min or 1 h at 37 °C, followed by western blot analysis. Note that Tau is strongly reduced (5 min) or even absent (1 h) in exosomes treated with both Prot K and Sapo, compared with treatment with Prot K alone, indicating that the exosomal membrane protects Tau against Prot K digestion
Fig. 3 Tau is localized inside exosomes. a Neuron-derived exosomes were incubated with increasing concentrations of NaCl to detach proteins peripherally attached to the membrane. Tau is detected with the pan-Tau antibody K9JA. HSC70 and Alix were examined as exosomal markers. Lines on the right indicate Tau protein, Alix and HSC70. M.W. markers are shown on the left. Note that exosomal Tau levels are not changed by NaCl treatment (lanes 1–5), similar to exosomal markers HSC70 and Alix, indicating that Tau is not peripherally attached to the exosomal membrane surface. b Proteinase K protection assay. Neuron-derived exosomes treated with or without 50 ng proteinase K (Prot K) in the presence or absence of 1% saponin (Sapo) for 5 min or 1 h at 37 °C, followed by western blot analysis. Note that Tau is strongly reduced (5 min) or even absent (1 h) in exosomes treated with both Prot K and Sapo, compared with treatment with Prot K alone, indicating that the exosomal membrane protects Tau against Prot K digestionCC BY · PubMed Central
Fig. 4 The uptake and trans-synaptic transmission of Tau by cultured rat primary neurons via exosomes in microfluidic chambers. a Western blot assay to analyze exosomes isolated from N2a cells transfected with TauGFP for 2 days. Note that only intact, no truncated TauGFP fusion protein was detected, and that TauGFP occurred both in the neuronal and exosomal compartments. b Nanoparticle tracking analysis of isolated exosomes. The distribution peaks around ~50 and ~80 nm, indicating the enrichment of exosomes in the preparations. c Cryo-electron tomography of isolated exosomes. The left panel (overview) shows several exosomes (arrows) with an estimated size of ~50–100 nm. The isosurface representation in the right panel shows two connected exosomes (the membranes are colored in blue and yellow respectively). d Uptake and transmission of TauGFP by neurons cultured in microfluidic chambers with short microgrooves (150 μm). The 1st order neurons were treated with TauGFP exosomes (20 μg) at DIV25 for 24 h, when the 2nd order neurons were at DIV11. Neurons were stained with antibodies against MAP2 (red) and tubulin (blue). Arrows indicate TauGFP positive vesicles. Note that TauGFP puncta were detected in the microgrooves (left panels) and also in the 2nd order neurons on the neuritic side (right panels) that were not treated with TauGFP exosomes, indicating the uptake and the transmission of TauGFP via exosomes between the two populations of neurons. Scale bar in Left panels = 20 μm; right panels = 10 μm. e Direct transmission of exosomes from 1st order neurons to the 2nd order neurons in microfluidic chambers. Neurons were treated as described in d. Neurons were stained with antibodies against MAP2 (blue) and Flotillin (red). Scale bar = 10 μm. Arrows indicate TauGFP exosomes. The colocalization of TauGFP with Flotillin indicates that Tau is indeed located in the exosomes. f Direct transmission of exosomes from 1st order neurons to the 2nd and 3rd order neurons in microfluidic chambers. The 1st order neurons were treated with TauRFP and FlotillinGFP positive exosomes (20 μg) at DIV24 for 24 h, when the 2nd and 3rd order neurons were at DIV17 and DIV10 respectively. Neurons were stained with antibodies against tubulin (blue). Majority of the puncta in 2nd (94.5 ± 3.7% of 220 puncta in 3 different microfluidic chambers) and 3rd populations (85.7 ± 7.1% of 105 puncta in 3 different microfludic chambers) of neurons were positive for both TauRFP and FlotillinGFP. Arrows indicate TauRFP and FlotillinGFP positive vesicles. Note that TauRFP and FlotillinGFP positive puncta were detected in the 2nd and 3rd order neurons that were not treated with exosomes, indicating the uptake and the direct transmission of exosomes between the three populations of neurons. Scale bar = 10 μm. g The transmission of TauGFP exosomes from axons of the 1st order neurons to the 2nd neurons cultured in microfluidic chambers with long microgrooves (900 nm). The 1st order neurons were treated with TauGFP exosomes (20 μg) at DIV25 for 24 h, when the 2nd order neurons were at DIV11. Neurons were stained with an antibody against tubulin (red). Scale bar = 10 μm. Arrows indicate TauGFP positive exosomes. Note that TauGFP puncta were detected in the microgrooves (left panel) and also in the 2nd order neurons on the neuritic side (right panels) that were not treated with exosomes. Since no dendrites project through the long microgrooves (900 μm) to the neuritic side, the transmission of TauGFP exosomes occurs through axons of the 1st order neuron to the 2nd order neurons
Fig. 4 The uptake and trans-synaptic transmission of Tau by cultured rat primary neurons via exosomes in microfluidic chambers. a Western blot assay to analyze exosomes isolated from N2a cells transfected with TauGFP for 2 days. Note that only intact, no truncated TauGFP fusion protein was detected, and that TauGFP occurred both in the neuronal and exosomal compartments. b Nanoparticle tracking analysis of isolated exosomes. The distribution peaks around ~50 and ~80 nm, indicating the enrichment of exosomes in the preparations. c Cryo-electron tomography of isolated exosomes. The left panel (overview) shows several exosomes (arrows) with an estimated size of ~50–100 nm. The isosurface representation in the right panel shows two connected exosomes (the membranes are colored in blue and yellow respectively). d Uptake and transmission of TauGFP by neurons cultured in microfluidic chambers with short microgrooves (150 μm). The 1st order neurons were treated with TauGFP exosomes (20 μg) at DIV25 for 24 h, when the 2nd order neurons were at DIV11. Neurons were stained with antibodies against MAP2 (red) and tubulin (blue). Arrows indicate TauGFP positive vesicles. Note that TauGFP puncta were detected in the microgrooves (left panels) and also in the 2nd order neurons on the neuritic side (right panels) that were not treated with TauGFP exosomes, indicating the uptake and the transmission of TauGFP via exosomes between the two populations of neurons. Scale bar in Left panels = 20 μm; right panels = 10 μm. e Direct transmission of exosomes from 1st order neurons to the 2nd order neurons in microfluidic chambers. Neurons were treated as described in d. Neurons were stained with antibodies against MAP2 (blue) and Flotillin (red). Scale bar = 10 μm. Arrows indicate TauGFP exosomes. The colocalization of TauGFP with Flotillin indicates that Tau is indeed located in the exosomes. f Direct transmission of exosomes from 1st order neurons to the 2nd and 3rd order neurons in microfluidic chambers. The 1st order neurons were treated with TauRFP and FlotillinGFP positive exosomes (20 μg) at DIV24 for 24 h, when the 2nd and 3rd order neurons were at DIV17 and DIV10 respectively. Neurons were stained with antibodies against tubulin (blue). Majority of the puncta in 2nd (94.5 ± 3.7% of 220 puncta in 3 different microfluidic chambers) and 3rd populations (85.7 ± 7.1% of 105 puncta in 3 different microfludic chambers) of neurons were positive for both TauRFP and FlotillinGFP. Arrows indicate TauRFP and FlotillinGFP positive vesicles. Note that TauRFP and FlotillinGFP positive puncta were detected in the 2nd and 3rd order neurons that were not treated with exosomes, indicating the uptake and the direct transmission of exosomes between the three populations of neurons. Scale bar = 10 μm. g The transmission of TauGFP exosomes from axons of the 1st order neurons to the 2nd neurons cultured in microfluidic chambers with long microgrooves (900 nm). The 1st order neurons were treated with TauGFP exosomes (20 μg) at DIV25 for 24 h, when the 2nd order neurons were at DIV11. Neurons were stained with an antibody against tubulin (red). Scale bar = 10 μm. Arrows indicate TauGFP positive exosomes. Note that TauGFP puncta were detected in the microgrooves (left panel) and also in the 2nd order neurons on the neuritic side (right panels) that were not treated with exosomes. Since no dendrites project through the long microgrooves (900 μm) to the neuritic side, the transmission of TauGFP exosomes occurs through axons of the 1st order neuron to the 2nd order neuronsCC BY · PubMed Central
Fig. 5 Synaptic contacts are required for exosome-mediated transmission of TauGFP. a Diagram illustrating the possible mechanisms underlying exosome-mediated Tau transmission. (i) Transmission occurs specifically through trans-synaptic connections from 1st order to 2nd order neurons. (ii) Exosomes in 1st order neurons are released into the conditioned medium and then internalized by 2nd order neurons. b Formation of synaptic contacts at different states of maturation. (b1, b2) Neurons were stained for post-synaptic marker GluR1 (green) and pre-synaptic marker synaptophysin (SynPh) (red). The co-localization of GluR1 and synaptophysin indicates formation of synaptic contacts (white arrows on right panel). Synaptic connections were formed in the 1st order mature neurons (DIV 25 or DIV18) on the somal side (b1, b2) and also in the 2nd order old neurons on the neuritic side (DIV11) (b3), but not in the 2nd order young neurons (DIV4) (b4). Scale bar = 10 μm. (b5) Quantification of synapse density shown in b1-b4. Synapses are formed in neurons at DIV11, although the density is lower than that in mature neurons (DIV18 and 25). Notably, nearly no synapses are formed in young neurons at DIV4. Error bars: SEM; n = 3 in b5. Student t-test: **p < 0.01. c No transmission of TauGFP exosomes from mature neurons (DIV18) to very young neurons (DIV4) cultured in microfluidic chambers. The 1st order neurons were treated with TauGFP exosomes (20 μg) at DIV18 for 24 h, when the 2nd order neurons were at DIV4. Neurons were stained with an antibody against tubulin (red). Scale bar in left panel = 20 μm; in right panel = 10 μm. Arrows indicate TauGFP positive exosomes in the microgrooves (left side, middle), but not in the 2nd order neurons on the neuritic side (right side, bottom) that were not treated with exosomes, indicating no transmission of TauGFP via exosomes between the two populations of neurons. d, e FACS analysis of the uptake of TauGFP exosomes by young (DIV4) and old neurons (DIV11). Neurons were treated with TauGFP exosomes (20 μg) for 24 h. Conditioned medium was collected immediately after the addition of TauGFP exosomes (Exo-0 h) or 24 h later (Exo-24 h) for flow cytometry. The left and middle panels show a representative readout of the flow cytometry. Right panel: quantification of 3 experiments. Note that TauGFP exosomes in conditioned medium is dramatically reduced after 24 h treatment, indicating the uptake of these exosomes by young and old neurons (DIV4 or DIV11). Error bars: SD; n = 4 and n = 3 in d and e respectively. Student t-test: *p < 0.05. f The internalization of TauGFP exosomes by young neurons (DIV4). Young neurons (DIV4) were treated with TauGFP exosomes (20 μg) for 24 h and then stained with an antibody against tubulin (red). Scale bar = 10 μm. Arrows indicate TauGFP positive exosomes. Note that TauGFP puncta are detected inside neurons, suggesting the uptake of TauGFP exosomes by young neurons. g, h FACS analysis showing that there is no release of TauGFP exosomes into conditioned medium on the neuritic side. The 1st order neurons cultured on the somal side in microfluidic chambers were treated with TauGFP exosomes (20 μg) for 24 h. Conditioned medium on the somal side or neuritic side was collected immediately after the addition of TauGFP exosomes (Exo-0 h) or 24 h later (Exo-24 h) for flow cytometry. The left 3 panels show a representative readout. The right panels: quantification of 3 experiments. Almost no TauGFP positive exosomes were detected in the conditioned medium on the neuritic side, indicating that the internalized TauGFP exosomes were not released into the conditioned medium on the neuritic side by the 1st order neurons. Error bars: SD, n = 3. Student t-test: ** p < 0.01. i Transmission of TauGFP exosomes from 1st order neurons to the 2nd and 3rd order neurons in triple-chamber devices. The 1st order neurons cultured in the 1st chamber were treated with TauGFP exosomes (20 μg) at DIV24 for 24 h. Neurons were stained with an antibody against tubulin (red). Arrows indicate TauGFP exosomes. Note the presence of TauGFP exosomes in all the three population of neurons indicating transmission of TauGFP via exosomes between the three different populations of neurons. Scale bars = 10 μm. j Quantification of the percentage of neurons in all the three channels with TauGFP exosomes. Error bars: SEM; n = 3. Student t-test: * p < 0.05, **p < 0.01
Fig. 5 Synaptic contacts are required for exosome-mediated transmission of TauGFP. a Diagram illustrating the possible mechanisms underlying exosome-mediated Tau transmission. (i) Transmission occurs specifically through trans-synaptic connections from 1st order to 2nd order neurons. (ii) Exosomes in 1st order neurons are released into the conditioned medium and then internalized by 2nd order neurons. b Formation of synaptic contacts at different states of maturation. (b1, b2) Neurons were stained for post-synaptic marker GluR1 (green) and pre-synaptic marker synaptophysin (SynPh) (red). The co-localization of GluR1 and synaptophysin indicates formation of synaptic contacts (white arrows on right panel). Synaptic connections were formed in the 1st order mature neurons (DIV 25 or DIV18) on the somal side (b1, b2) and also in the 2nd order old neurons on the neuritic side (DIV11) (b3), but not in the 2nd order young neurons (DIV4) (b4). Scale bar = 10 μm. (b5) Quantification of synapse density shown in b1-b4. Synapses are formed in neurons at DIV11, although the density is lower than that in mature neurons (DIV18 and 25). Notably, nearly no synapses are formed in young neurons at DIV4. Error bars: SEM; n = 3 in b5. Student t-test: **p < 0.01. c No transmission of TauGFP exosomes from mature neurons (DIV18) to very young neurons (DIV4) cultured in microfluidic chambers. The 1st order neurons were treated with TauGFP exosomes (20 μg) at DIV18 for 24 h, when the 2nd order neurons were at DIV4. Neurons were stained with an antibody against tubulin (red). Scale bar in left panel = 20 μm; in right panel = 10 μm. Arrows indicate TauGFP positive exosomes in the microgrooves (left side, middle), but not in the 2nd order neurons on the neuritic side (right side, bottom) that were not treated with exosomes, indicating no transmission of TauGFP via exosomes between the two populations of neurons. d, e FACS analysis of the uptake of TauGFP exosomes by young (DIV4) and old neurons (DIV11). Neurons were treated with TauGFP exosomes (20 μg) for 24 h. Conditioned medium was collected immediately after the addition of TauGFP exosomes (Exo-0 h) or 24 h later (Exo-24 h) for flow cytometry. The left and middle panels show a representative readout of the flow cytometry. Right panel: quantification of 3 experiments. Note that TauGFP exosomes in conditioned medium is dramatically reduced after 24 h treatment, indicating the uptake of these exosomes by young and old neurons (DIV4 or DIV11). Error bars: SD; n = 4 and n = 3 in d and e respectively. Student t-test: *p < 0.05. f The internalization of TauGFP exosomes by young neurons (DIV4). Young neurons (DIV4) were treated with TauGFP exosomes (20 μg) for 24 h and then stained with an antibody against tubulin (red). Scale bar = 10 μm. Arrows indicate TauGFP positive exosomes. Note that TauGFP puncta are detected inside neurons, suggesting the uptake of TauGFP exosomes by young neurons. g, h FACS analysis showing that there is no release of TauGFP exosomes into conditioned medium on the neuritic side. The 1st order neurons cultured on the somal side in microfluidic chambers were treated with TauGFP exosomes (20 μg) for 24 h. Conditioned medium on the somal side or neuritic side was collected immediately after the addition of TauGFP exosomes (Exo-0 h) or 24 h later (Exo-24 h) for flow cytometry. The left 3 panels show a representative readout. The right panels: quantification of 3 experiments. Almost no TauGFP positive exosomes were detected in the conditioned medium on the neuritic side, indicating that the internalized TauGFP exosomes were not released into the conditioned medium on the neuritic side by the 1st order neurons. Error bars: SD, n = 3. Student t-test: ** p < 0.01. i Transmission of TauGFP exosomes from 1st order neurons to the 2nd and 3rd order neurons in triple-chamber devices. The 1st order neurons cultured in the 1st chamber were treated with TauGFP exosomes (20 μg) at DIV24 for 24 h. Neurons were stained with an antibody against tubulin (red). Arrows indicate TauGFP exosomes. Note the presence of TauGFP exosomes in all the three population of neurons indicating transmission of TauGFP via exosomes between the three different populations of neurons. Scale bars = 10 μm. j Quantification of the percentage of neurons in all the three channels with TauGFP exosomes. Error bars: SEM; n = 3. Student t-test: * p < 0.05, **p < 0.01CC BY · PubMed Central
Fig. 6 Uptake of TauGFP exosomes by neurons and microglia in cultured organotypic hippocampal slices. a Immunofluorescence assay showing the uptake of TauGFP exosomes by hippocampal slice cultures. Hippocampal slice cultures were incubated for 24 h with exosomes (20 μg) isolated from N2a cells expressing TauGFP. Cultures were afterwards stained for neuronal marker MAP2 (red, a1), microglial marker Iba1 (red, a2, a3) or astrocytic marker GFAP (red, a4). TauGFP colocalizes with MAP2 (A1) and Iba1 (a2, a3) suggesting the uptake of exosomes by neurons (a1) and microglia (a2, a3). Nearly no colocalization of TauGFP with GFAP is observed (a4), indicating no internalization of exosomes by astrocytes. Scale bars = 10 μm. b Quantification of the uptake of TauGFP exosomes by neurons, microglia and astrocytes shown in (a). Significantly higher percentage of microglia (24.8 ± 14.1%) than neurons (12.3 ± 11.2%) exhibits uptake of exosomes (n = 22–24 slices). Nearly no uptake of exosomes is observed in astrocytes. Error bars: SEM. ANOVA: *** p < 0.001
Fig. 6 Uptake of TauGFP exosomes by neurons and microglia in cultured organotypic hippocampal slices. a Immunofluorescence assay showing the uptake of TauGFP exosomes by hippocampal slice cultures. Hippocampal slice cultures were incubated for 24 h with exosomes (20 μg) isolated from N2a cells expressing TauGFP. Cultures were afterwards stained for neuronal marker MAP2 (red, a1), microglial marker Iba1 (red, a2, a3) or astrocytic marker GFAP (red, a4). TauGFP colocalizes with MAP2 (A1) and Iba1 (a2, a3) suggesting the uptake of exosomes by neurons (a1) and microglia (a2, a3). Nearly no colocalization of TauGFP with GFAP is observed (a4), indicating no internalization of exosomes by astrocytes. Scale bars = 10 μm. b Quantification of the uptake of TauGFP exosomes by neurons, microglia and astrocytes shown in (a). Significantly higher percentage of microglia (24.8 ± 14.1%) than neurons (12.3 ± 11.2%) exhibits uptake of exosomes (n = 22–24 slices). Nearly no uptake of exosomes is observed in astrocytes. Error bars: SEM. ANOVA: *** p < 0.001CC BY · PubMed Central
Fig. 7 Tau aggregates are preferentially released via exosomes by a cell model of tauopathy, which can induce aggregation of Tau in N2a cells. Tet-inducible N2a cells were induced to express TauRDΔK for 2 days by addition of doxycyclin. Then the cells were harvested for sarkosyl extraction to separate soluble Tau and insoluble Tau. The conditioned medium was collected for isolation of exosomes. S and P denote supernatant and pellet of sarkosyl extraction respectively. a TauRDΔK aggregates in N2a cells and in exosomes. Soluble Tau and Tau aggregates in N2a cells expressing TauRDΔK or exosomes from this cell model were separated by sarkosyl extraction. The protein loading ratio between supernatant and pellet for N2a cells was 1:60, for exosomes was 1:9. Note that fragment F2 and F3 were detected in pellet of cell extracts but not in pellet of exosomal extracts. b Quantification of TauRDΔK shown in (a). Note that much more TauRDΔK aggregates were detected in exosomes than in N2a cells. Error bars: SD; n = 3. Student t-test: ** p < 0.01. c Analysis of isolated exosomes separated by sucrose gradient centrifugation. TauRDΔK appears in fraction 4, coincident with the exosomal marker Alix. d Analysis of sarkosyl pellet of cell lysates separated by sucrose gradient centrifugation. TauRDΔK is enriched in fraction 1 and 9, but not in fraction 4-- the fraction shown to contain exosomes in (c). This indicates that the presence of TauRDΔK in exosomes is not due to the contamination of Tau aggregates. e Nanotracking analysis of isolated exosomes. The size distribution peaks at ~100 nm, which is typical for exosomes. f Atomic force microscopy of isolated exosomes. The diameters of the majority of the vesicles are 40–100 nm. The average diameter of the exosomes isolated from N2a cells expressing TauRDΔK is 67.2 ± 15.3 nm and the average height is 2.2 ± 0.8 nm. The exosomes appear to be disk-like shaped. g Cryo-electron tomography of isolated exosomes (compare Fig. 1g). h Induction of aggregation of full-length TauΔK in N2a cells by exosomes from N2a cells expressing TauRDΔK. N2a cells were transfected with pro-aggregant TauΔK and induced to express the protein for 1 day. Then the cells were treated with exosomes (20 μg) derived from N2a cells expressing TauRDΔK and continuously induced to express TauΔK for additional 2 days. TauΔK was labeled with K9JA antibody (red). Thioflavine S staining was performed to monitor Tau aggregates (green, arrow). Hoechst staining was used to label nuclei (blue). Note that ThS positive cells were detected in N2a cells (~20-30/3-4X104 cells, repeated 3 times) treated with exosomes containing TauRDΔK, but not in N2a cells treated with broken exosomes. Arrow indicates Tau aggregates. Scale bars = 10 μm
Fig. 7 Tau aggregates are preferentially released via exosomes by a cell model of tauopathy, which can induce aggregation of Tau in N2a cells. Tet-inducible N2a cells were induced to express TauRDΔK for 2 days by addition of doxycyclin. Then the cells were harvested for sarkosyl extraction to separate soluble Tau and insoluble Tau. The conditioned medium was collected for isolation of exosomes. S and P denote supernatant and pellet of sarkosyl extraction respectively. a TauRDΔK aggregates in N2a cells and in exosomes. Soluble Tau and Tau aggregates in N2a cells expressing TauRDΔK or exosomes from this cell model were separated by sarkosyl extraction. The protein loading ratio between supernatant and pellet for N2a cells was 1:60, for exosomes was 1:9. Note that fragment F2 and F3 were detected in pellet of cell extracts but not in pellet of exosomal extracts. b Quantification of TauRDΔK shown in (a). Note that much more TauRDΔK aggregates were detected in exosomes than in N2a cells. Error bars: SD; n = 3. Student t-test: ** p < 0.01. c Analysis of isolated exosomes separated by sucrose gradient centrifugation. TauRDΔK appears in fraction 4, coincident with the exosomal marker Alix. d Analysis of sarkosyl pellet of cell lysates separated by sucrose gradient centrifugation. TauRDΔK is enriched in fraction 1 and 9, but not in fraction 4-- the fraction shown to contain exosomes in (c). This indicates that the presence of TauRDΔK in exosomes is not due to the contamination of Tau aggregates. e Nanotracking analysis of isolated exosomes. The size distribution peaks at ~100 nm, which is typical for exosomes. f Atomic force microscopy of isolated exosomes. The diameters of the majority of the vesicles are 40–100 nm. The average diameter of the exosomes isolated from N2a cells expressing TauRDΔK is 67.2 ± 15.3 nm and the average height is 2.2 ± 0.8 nm. The exosomes appear to be disk-like shaped. g Cryo-electron tomography of isolated exosomes (compare Fig. 1g). h Induction of aggregation of full-length TauΔK in N2a cells by exosomes from N2a cells expressing TauRDΔK. N2a cells were transfected with pro-aggregant TauΔK and induced to express the protein for 1 day. Then the cells were treated with exosomes (20 μg) derived from N2a cells expressing TauRDΔK and continuously induced to express TauΔK for additional 2 days. TauΔK was labeled with K9JA antibody (red). Thioflavine S staining was performed to monitor Tau aggregates (green, arrow). Hoechst staining was used to label nuclei (blue). Note that ThS positive cells were detected in N2a cells (~20-30/3-4X104 cells, repeated 3 times) treated with exosomes containing TauRDΔK, but not in N2a cells treated with broken exosomes. Arrow indicates Tau aggregates. Scale bars = 10 μmCC BY · PubMed Central
Fig. 8 Exosomes isolated from CSF of AD or control subjects contain Tau and induce TauRDΔK aggregation. a The presence of Tau monomers and trimers in exosomes determined with western blots. Besides Tau monomers, Tau trimers (indicated by arrowheads, top right) ran around 180kD were detected in both exosomes from AD and controls. These Tau trimers were phosphorylated at 12E8 sites (a2) and PHF1 (a3). Two Tau monomer bands were also phosphorylated at PHF1 sites and 12E8 sites (indicated with arrows). Between the phosphorylated Tau monomer bands, other Tau bands were not phosphorylated at PHF1 and 12E8 sites (a1, indicated by *). b Tau in CSF before isolation of exosomes. Monomeric Tau (doublet between Mr 55-70kD (indicated by arrows), but no Tau oligomers of ~180kD was detected. c Quantification of Tau shown in a. No significant differences of the amount of total Tau (c1) and Tau phosphorylated at 12E8 sites (c2) and PHF1 sites (c3) were observed between exosomes isolated from AD and controls. Error bars: SD. Student t-test: n.s., not significant. d Diagram showing the luciferase protein-fragment complementation assay. N2a cells were co-transfected with TauRDΔK fused to split luciferase constructs (N: N-terminal part of luciferase, C: C-terminal part of luciferase). A luminescence signal is only detected after complementation of both split luciferase fragments (e.g. during dimerization and oligomerization of TauRDΔK) and indicates the induction of TauRDΔK aggregation. e Promotion of TauRDΔK aggregation by exosomes from human CSF. Luminescence increases in reporter cells upon treatment with exosomes prepared from equal volumes of CSF from AD (n = 13) or controls (n = 13). All measurements were performed in triplicates. **, p < 0.001, n.s., non-significant, one way ANOVA
Fig. 8 Exosomes isolated from CSF of AD or control subjects contain Tau and induce TauRDΔK aggregation. a The presence of Tau monomers and trimers in exosomes determined with western blots. Besides Tau monomers, Tau trimers (indicated by arrowheads, top right) ran around 180kD were detected in both exosomes from AD and controls. These Tau trimers were phosphorylated at 12E8 sites (a2) and PHF1 (a3). Two Tau monomer bands were also phosphorylated at PHF1 sites and 12E8 sites (indicated with arrows). Between the phosphorylated Tau monomer bands, other Tau bands were not phosphorylated at PHF1 and 12E8 sites (a1, indicated by *). b Tau in CSF before isolation of exosomes. Monomeric Tau (doublet between Mr 55-70kD (indicated by arrows), but no Tau oligomers of ~180kD was detected. c Quantification of Tau shown in a. No significant differences of the amount of total Tau (c1) and Tau phosphorylated at 12E8 sites (c2) and PHF1 sites (c3) were observed between exosomes isolated from AD and controls. Error bars: SD. Student t-test: n.s., not significant. d Diagram showing the luciferase protein-fragment complementation assay. N2a cells were co-transfected with TauRDΔK fused to split luciferase constructs (N: N-terminal part of luciferase, C: C-terminal part of luciferase). A luminescence signal is only detected after complementation of both split luciferase fragments (e.g. during dimerization and oligomerization of TauRDΔK) and indicates the induction of TauRDΔK aggregation. e Promotion of TauRDΔK aggregation by exosomes from human CSF. Luminescence increases in reporter cells upon treatment with exosomes prepared from equal volumes of CSF from AD (n = 13) or controls (n = 13). All measurements were performed in triplicates. **, p < 0.001, n.s., non-significant, one way ANOVACC BY · PubMed Central
Fig. 9 Diagram of exosome-mediated Tau transmission. (1) When Tau-containing exosomes are released into extracellular space, they can be taken up by neurons. (2) The internalized exosomes undergo axonal transport and finally are released at pre-synaptic terminals. (3) The released exosomes are taken up by the synaptically connected neurons, resulting in the distribution of Tau in these recipient cells
Fig. 9 Diagram of exosome-mediated Tau transmission. (1) When Tau-containing exosomes are released into extracellular space, they can be taken up by neurons. (2) The internalized exosomes undergo axonal transport and finally are released at pre-synaptic terminals. (3) The released exosomes are taken up by the synaptically connected neurons, resulting in the distribution of Tau in these recipient cellsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Cited by

See all 675

Metadata

Authors
Wang, Y., Balaji, V., Kaniyappan, S., Krüger, L., Irsen, S., Tepper, K., Chandupatla, R., Maetzler, W., Schneider, A., Mandelkow, E., & Mandelkow, E.-M.
Affiliations
  • German Center for Neurodegenerative Diseases (DE)
  • Center of Advanced European Studies and Research (DE)
  • University of Tübingen (DE)
Corresponding author
  • Wang, Yipeng
  • Mandelkow, Eva-Maria
Venue
Molecular Neurodegeneration
Published
2017-01-13
Volume
12
Issue
1
Pages
5-5
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2574784626
Cited by
674
References
62
Citations by year
2026: 47 · 2025: 59 · 2024: 77 · 2023: 85 · 2022: 75 · 2021: 106 · 2020: 72 · 2019: 72 · 2018: 62 · 2017: 19
FWCI
45.54
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel) (submittedVersion, cc-by)
  • MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
  • Max Planck Digital Library (submittedVersion, other-oa)
  • DZNE Pub (submittedVersion, cc-by)
  • GRO (submittedVersion, cc-by)
Funders
  • Deutsche Forschungsgemeinschaft
  • Max-Planck-Gesellschaft
  • Deutsches Zentrum für Neurodegenerative Erkrankungen
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
tau protein, exosomes, Alzheimer's disease, tauopathy, neuronal depolarization, tau phosphorylation, microglia, organotypic hippocampal slices, tau aggregation, split luciferase complementation, microfluidic cell culture
MeSH terms
Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Enzyme-Linked Immunosorbent Assay, Female, Flow Cytometry, Fluorescent Antibody Technique, Humans, Male, Middle Aged, Neurons, tau Proteins, Disease Progression, Microscopy, Atomic Force, Cryoelectron Microscopy, Protein Transport, Tauopathies, Microfluidic Analytical Techniques, Mice, Rats, Exosomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The release and trans-synaptic transmission of Tau via exosomes. https://app.cochat.ai/papers/10.1186/s13024-016-0143-y
The paper
Wang, Y., Balaji, V., Kaniyappan, S., Krüger, L., Irsen, S., Tepper, K., Chandupatla, R., Maetzler, W., Schneider, A., Mandelkow, E., & Mandelkow, E.-M. (2017). The release and trans-synaptic transmission of Tau via exosomes. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-016-0143-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.